Rankings
▼
Calendar
KMDA Q2 2023 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena
KMDA
Kamada Ltd.
$520M
Q2 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$37M
+58.7% YoY
Gross Profit
$14M
38.6% margin
Operating Income
$3M
7.0% margin
Net Income
$2M
4.8% margin
EPS (Diluted)
$0.04
QoQ Revenue Growth
+21.9%
Cash Flow
Operating Cash Flow
$2M
Free Cash Flow
$770,000
Stock-Based Comp.
$214,000
Balance Sheet
Total Assets
$314M
Total Liabilities
$138M
Stockholders' Equity
$177M
Cash & Equivalents
$22M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$37M
$24M
+58.7%
Gross Profit
$14M
$7M
+99.4%
Operating Income
$3M
-$2M
+214.7%
Net Income
$2M
-$4M
+146.2%
← FY 2023
All Quarters
Q3 2023 →